News Research Pancreatic Cancer Gastrointestinal Cancers

Machine Learning Identifies Non–Guideline-Concordant Treatment in Pancreatic Cancer

June 15, 2026 By ASCO AI Staff 12 min watch
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter

Annabelle Fonseca, MD, MHS, discusses her poster presentation from the 2026 ASCO Annual Meeting, about the use of machine learning and electronic health records to identify patients with pancreatic cancer who are at risk for receiving treatment that is not aligned with guidelines. The findings suggest that machine learning models could be used to trigger early referrals to navigation and supportive services to potentially improve patient outcomes.

Related Content